263 related articles for article (PubMed ID: 15766030)
1. [Also for problem cases; successful first line therapy].
MMW Fortschr Med; 2005 Feb; 147(5):47. PubMed ID: 15766030
[No Abstract] [Full Text] [Related]
2. Calcium channel blocker.
Li CJ; Shi ZD
Clin Ther; 2010 Feb; 32(2):396; author reply 397. PubMed ID: 20206797
[No Abstract] [Full Text] [Related]
3. [Hypertension in type 2 diabetic patients. Calcium antagonist supports the left heart].
MMW Fortschr Med; 2001 Jun; 143(25):58. PubMed ID: 11469003
[No Abstract] [Full Text] [Related]
4. [Drug information about lercanidipine. A new dihydropyridine calcium antagonist for the treatment of arterial hypertension].
Christensen KL
Ugeskr Laeger; 2005 Jan; 167(2):153-5. PubMed ID: 15697124
[No Abstract] [Full Text] [Related]
5. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
Zanchetti A
Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
[No Abstract] [Full Text] [Related]
6. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
Chatzikyrkou C; Haller H; Menne J
Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive therapy. Can a calcium antagonist stop arteriosclerosis?].
MMW Fortschr Med; 2001 May; 143(22):53. PubMed ID: 11460409
[No Abstract] [Full Text] [Related]
8. [Lowering blood pressure with new calcium antagonists. High benefit by innovative mechanism of action].
MMW Fortschr Med; 2005 Feb; 147(5):46-7. PubMed ID: 15766029
[No Abstract] [Full Text] [Related]
9. Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release.
Takahara A
Cardiovasc Ther; 2009; 27(2):124-39. PubMed ID: 19426250
[TBL] [Abstract][Full Text] [Related]
10. [Dihydropyridines for treatment of arterial hypertension].
Bareza N; Gasser S; Toferer E; Scheer E; Pruthi D; Gasser R
Pharm Unserer Zeit; 2005; 34(5):388-91. PubMed ID: 16180361
[No Abstract] [Full Text] [Related]
11. Role of dihydropyridinic calcium channel blockers in the management of hypertension.
Coca A; Mazón P; Aranda P; Redón J; Divisón JA; Martínez J; Calvo C; Galcerán JM; Barrios V; Roca-Cusachs I Coll A
Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):91-105. PubMed ID: 23259449
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers. Lessons learned from MIDAS and other clinical trials.
Chobanian AV
JAMA; 1996 Sep; 276(10):829-30. PubMed ID: 8769595
[No Abstract] [Full Text] [Related]
13. Lercanidipine in hypertension.
Borghi C
Vasc Health Risk Manag; 2005; 1(3):173-82. PubMed ID: 17319103
[TBL] [Abstract][Full Text] [Related]
14. [[Antihypertensive therapy and organ protection].
Stella ML; Grassi G; Paleari F; Gamba P; Mancia G
Cardiologia; 1996 May; 41 Suppl 1():19-23. PubMed ID: 8831177
[No Abstract] [Full Text] [Related]
15. Clinical advantages of lipophilic dihydropyridines.
Mancia G; Omboni S; Zanchetti A
Blood Press Suppl; 1998; 2():23-6. PubMed ID: 9850439
[TBL] [Abstract][Full Text] [Related]
16. [Dihydropyridines are not the only antihypertensives. Calcium blockers in the therapy of elderly hypertensive patients].
Fortschr Med Suppl; 1989; 71():1-18. PubMed ID: 2635677
[No Abstract] [Full Text] [Related]
17. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
Burnier M; Pruijm M; Wuerzner G
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
[TBL] [Abstract][Full Text] [Related]
18. [Lercanidipine, a third generation calcium antagonist. Which advantages?].
Meier P; Burnier M
Rev Med Suisse; 2006 Sep; 2(78):2047-50, 2052-3. PubMed ID: 17019840
[TBL] [Abstract][Full Text] [Related]
19. Clevidipine (Cleviprex) for IV treatment of severe hypertension.
Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023
[No Abstract] [Full Text] [Related]
20. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
Koh KK; Quon MJ; Lee SJ; Han SH; Ahn JY; Kim JA; Chung WJ; Lee Y; Shin EK
Diabetes Care; 2007 Jun; 30(6):1605-7. PubMed ID: 17351278
[No Abstract] [Full Text] [Related]
[Next] [New Search]
